Microport EP and Stereotaxis Form Robotic Ablation Device Collaboration

Shanghai Microport EP Medtech and Stereotaxis of St. Louis will collaborate to develop advanced robotic electophysiology devices. The companies will combine MicroPort EP’s electrophysiology products with Stereotaxis’ advanced Robotic Magnetic Navigation technology. MicroPort EP will become the exclusive distributor of Stereotaxis’ electrophysiology technology in China . The companies will integrate MicroPort EP’s Columbus® mapping system with Stereotaxis’ robotic systems, and they will work together to develop a family of cardiac ablation and diagnostic catheters. More details.... Stock Symbol: (NYSE: STXS) Share this with colleagues: // //
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.